A Study of Cardiovascular Events iN Diabetes Plus
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 21296 participants.
Also called NCT05441267
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 21,296 participants
- Sponsor
- Registry
-
NCT05441267
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05441267. Randomized; quadruple masking; primary purpose prevention. Start 2023-03-13 (actual); primary completion 2028-08-17 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Cardiovascular Events iN Diabetes Plus
- Acronym
- ASCEND PLUS
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Semaglutide Oral Tablet
- Intervention (Drug)
- Placebo oral tablet
- Lead sponsor
- University of Oxford
- Collaborator
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct05441267- Content hash
00d3819a2afca3b1d305e305312598e0275d13de25f39eccd555fa9565cce846